Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials

Overview

We are leveraging the power of the dark genome to develop precise and potent RNA therapies for disease driving cell-state reprogramming.

News

Blog 2 months ago
HAYA Therapeutics Receives FDA Fast Track Designation for HTX-001
HTX-001 is in a Phase 1a/b trial and being developed for the treatment of nonobstructive hypertrophic cardiomyopathy (nHCM) LAUSANNE, Switzerland and SAN DIEGO - July 28, 2026 - HAYA Therapeutics SA, a clinical-stage biotechnology company pioneering preci
Read more
Report
Blog 4 months ago
HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Clinical Trial of HTX-001
HTX-001 is a first-in-class antisense oligonucleotide designed to downregulate WISPER lncRNA, a driver of fibrosis in the heart . Phase 1a/b trial to evaluate the safety and tolerability of HTX-001 in healthy volunteers, followed by patients with nonobstr
Read more
Report
Blog 1 year ago
HAYA Therapeutics Moves San Diego Operations to Lilly Gateway Labs
LAUSANNE, Switzerland and SAN DIEGO, USA -Tuesday, June 3, 2025 - HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram disease-driving cell states for rare, common, chronic
Read more
Report
Press release 1 year ago
HAYA Therapeutics Raises $65 Million in Series A Funding
To Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases
Read more
Report
Pro access
Upgrade to see all 17 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

Tech stack

Technologies named in job postings at HAYA Therapeutics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
6
Postings analysed
2
Stack modernity
72/100AI adopter
Cloud & platforms
GCP
AI & ML
LLM
Practices & domains
Digital Twin
Human-in-the-Loop
Multi-Agent Systems
RAG
Sign in to see how your skills match this stack Sign In

Growth

Hiring Momentum
44/100
Stable
Open positions
3
1 opened / 0 closed in 30 days
Median time-to-fill
20 days
faster than 52% of the market
ATS activity
Every ~6 hours
Today
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
50% ▲
Product
25% ▲
Industrial Engineering
25% ▲

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
San Diego
San Diego United States
Engineering / R&D
3 open roles 3 posted in 90 days 67% engineering 50-200 est. staff
hires for Science & Research, Industrial Engineering
seen since Aug 2026 job postings